Drug Shortage Report for VENLAFAXINE XR

Last updated on 2020-02-06 History
Report ID 101823
Drug Identification Number 02354721
Brand name VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 75MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-20
Estimated end date 2020-02-05
Actual end date 2020-02-05
Shortage status Resolved
Updated date 2020-02-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-02-06 English Compare
v9 2020-02-05 French Compare
v8 2020-02-05 English Compare
v7 2020-02-05 French Compare
v6 2020-02-05 English Compare
v5 2020-02-03 French Compare
v4 2020-02-03 English Compare
v3 2019-12-21 English Compare
v2 2019-12-20 French Compare
v1 2019-12-20 English Compare

Showing 1 to 10 of 10